Belgium vs IDA blend: Cause of death, by non-communicable diseases, male
Belgium
75.8%
in 2021
IDA blend
38.3%
in 2021
Belgium rank
38th
IDA blend rank
38th
Cause of death, by non-communicable diseases, male over time
- Belgium
- IDA blend
How they compare
Belgium currently reports 75.8% against 38.3% in IDA blend, a difference of 37.5%.
That makes Belgium's figure about 2.0 times IDA blend's.
Across all 6 years both countries report, Belgium has been ahead every year.
Belgium ranks 38th and IDA blend ranks 38th of 185 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 85.1% | 28.8% | 56.3% | Belgium |
| 2010s | 85.3% | 37.4% | 47.9% | Belgium |
| 2020s | 72.8% | 39.0% | 33.8% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Belgium or IDA blend?
- Belgium, at 75.8% against 38.3% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Belgium and IDA blend?
- 37.5%, with Belgium ahead.
- How many years of comparable data are there for Belgium and IDA blend?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and IDA blend rank globally for cause of death, by non-communicable diseases, male?
- Belgium ranks 38th and IDA blend ranks 38th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.